Citicoline and Attention: Inside the McGlade Adolescent-Males Trial

Citicoline and Attention: Inside the McGlade Adolescent-Males Trial

Most nootropic claims fall apart the moment you ask for the data. The citicoline attention study that keeps surviving that question is the one Erin McGlade and her team at the University of Utah ran on healthy adolescent males. It is small, it is specific, and it found something real: a daily choline-pathway compound moved attention and motor speed in 28 days.

That last detail matters. Twenty-eight days. This was not a single-dose lab trick, but a month of supplementation that changed how a group of young men performed on attention tasks.

Here is what the trial tested, what it found, and where the result holds up versus where it gets oversold.

Key Takeaways

• The mcglade citicoline trial was a 28-day, randomized, double-blind, placebo-controlled study in healthy adolescent males.
• Participants taking citicoline showed better attention and faster citicoline psychomotor speed than placebo over the four weeks.
• The doses studied were citicoline 250 mg 500 mg daily, and a higher weight-adjusted dose was linked to better attention.
• Citicoline works slowly, by feeding the choline pathways your brain uses to build cell membranes and acetylcholine. It is a base layer, not an acute switch.

What the Citicoline Attention Study Actually Measured

The McGlade trial recruited healthy adolescent males and split them into groups taking placebo, 250 mg citicoline, or 500 mg citicoline per day for 28 days. The published paper is titled "The Effect of Citicoline Supplementation on Motor Speed and Attention in Adolescent Males," and it ran in the Journal of Attention Disorders.

The design is the part that earns trust. Randomized, double-blind, placebo-controlled. Neither the participants nor the people scoring the tests knew who got what.

The team measured attention and motor speed using standardized computerized cognitive tasks before and after the window. The question was simple. After a month, does the citicoline group perform differently from placebo?

The Result: Attention and Psychomotor Speed Improved

Citicoline supplementation was linked to improved attention and faster psychomotor speed compared with placebo across the 28-day window. That is the headline, and it is the reason this trial gets cited in nearly every serious citicoline review.

There was also a dose signal. When the researchers adjusted intake for body weight, a higher weight-adjusted dose of citicoline was linked to better attention, including accuracy and signal detection on the computerized tasks. Within the 250 to 500 mg range tested, more tended to track with a slightly bigger effect, not less.

For anyone scanning supplement labels, this is useful. Both studied doses sat in the everyday retail range, and the citicoline young men data point toward dosing inside that 250 to 500 mg window rather than chasing megadoses far above it.

A caveat worth stating plainly. This was one trial, in one narrow population, with a modest sample. Adolescent male brains are still developing, so you cannot copy-paste these numbers onto a 45-year-old executive and expect the same curve. The finding is strong evidence that citicoline does something to attention systems, not proof of a universal dose for everyone.

Why Citicoline Touches Attention in the First Place

Citicoline is the supplement form of CDP-choline, a molecule your body already makes. Once you take it, it breaks down and then rebuilds into two things your neurons need.

The first is phosphatidylcholine, a core building block of the membranes that wrap every brain cell. The second pathway feeds choline toward acetylcholine, the neurotransmitter most tied to attention and memory. According to Wikipedia's citicoline overview, the brain preferentially uses choline to make acetylcholine, which can compete with the choline needed for membrane repair.

That competition is the whole mechanism in one sentence. When choline is scarce, neurons may strip phosphatidylcholine from their own membranes to keep making acetylcholine, a process researchers describe in the Alzheimer's Drug Discovery Foundation's citicoline review as a kind of self-cannibalism. Supplementing choline relieves that pressure.

This is why citicoline is a slow build. You are topping up a raw material your brain uses for maintenance, not flipping a switch. The McGlade result took 28 days for a reason.

How the McGlade Doses Compare to Common Citicoline Products

Most citicoline supplements sold for focus land in the same range the trial used. Here is how the studied doses line up against what you typically see on a label.

The takeaway from the citicoline focus research is to stay inside the studied 250 to 500 mg daily window, which covers what most quality products offer, rather than chasing megadoses the trial never tested.

If you want the wider context on how choline ingredients fit a daily routine, our breakdown of the best nootropics for focus and our guide to caffeine and L-theanine for attention cover the acute side of the equation.

What This Trial Does Not Prove

Citicoline is not a stimulant, and the McGlade study did not test it as one. You will not feel a 250 mg capsule kick in during a meeting. The benefit, if you get it, accrues quietly over weeks as your choline status improves.

It also was not a study of adults, of women, or of people under heavy cognitive load at work. The clean result in citicoline young men is a starting point for those populations, not a finished answer.

And it is a supplement, not a treatment. Citicoline supports attention systems. It does not fix sleep debt, a scattered calendar, or a job that demands eight hours of output from a brain you have given four hours of rest.

Frequently Asked Questions

What did the McGlade citicoline study find?

The trial found that healthy adolescent males taking citicoline for 28 days showed improved attention and faster psychomotor speed compared with a placebo group. It was a randomized, double-blind, placebo-controlled design, which is why it is treated as solid evidence. The effect appeared at both 250 mg and 500 mg daily doses.

Was the 500 mg dose better than 250 mg?

The trial pooled both active doses against placebo, so it was not a clean head-to-head. But when the researchers adjusted for body weight, a higher weight-adjusted dose of citicoline was linked to better attention scores. That points toward dose mattering inside the 250 to 500 mg range, with the higher end edging out the lower on the attention measures.

How long does citicoline take to work?

Citicoline is a slow-acting ingredient. The McGlade benefits emerged over a 28-day supplementation period, not within a single session. Because citicoline works by topping up the raw materials your neurons use to build membranes and acetylcholine, the effect accumulates gradually. Expect a base-layer benefit measured in weeks, not an acute lift you feel in minutes.

Does citicoline help attention in adults?

The McGlade trial studied adolescent males, so it does not directly prove an effect in adults. Other citicoline research in adult populations has reported attention and memory benefits, but the doses, ages, and tasks vary. The adolescent-male result is strong support that citicoline engages attention systems, with adult-specific dosing still an open area.

Is citicoline a stimulant?

No. Citicoline does not act like caffeine or other stimulants and produces no acute jolt. It supports the cholinergic pathway your brain uses for attention and the phospholipids that make up neuronal membranes. That is a maintenance and supply mechanism, which is why benefits build slowly rather than hitting fast.

What dose of citicoline should I look for?

The McGlade trial used 250 mg and 500 mg daily, and most retail citicoline products fall in that range. A higher weight-adjusted dose tracked with better attention in the study, so the 500 mg end has support, though both doses sat in the active group that beat placebo. Consistency over several weeks matters as much as the exact milligram count.

The Slow Base and the Fast Lift Are Two Different Tools

The McGlade trial is a clean argument for choline-pathway support as a daily habit. You take it for weeks, your brain restocks the materials it uses for attention, and the payoff shows up as steadier performance over time. That is genuinely useful, and it is exactly what a base-layer ingredient should do.

But a 28-day base does not help you at 9 a.m. on a deadline. That is a different problem on a different clock, and it is the gap Roon is built for. Roon is a zero-nicotine sublingual pouch with a 4-ingredient stack: 80 mg caffeine, 60 mg L-theanine, 25 mg methylliberine (Dynamine), and 5 mg theacrine (TeaCrine). It works through the cheek in about 5 to 10 minutes and holds for 6 to 8 hours with no jitters, no crash, and no tolerance buildup.

Think of them as two timescales, not rivals. A choline supplement like the one McGlade studied is the slow base you build over a month. Roon is the acute lift you feel the same session. If you want focus you can notice now while you let the slower stuff accumulate, that is where it fits.

Written by Roon Team